Ask AI
ProCE Banner Activity

Interactive Case Challenges: Atopic Dermatitis and IL-4/IL-13 and IL-13 Targeted Therapies

Case Challenge

In this Interactive Case Challenge, explore the role of the IL-4/IL-13 pathway in the pathophysiology of moderate to severe atopic dermatitis, identify patients most likely to benefit from targeted biologic therapies, and evaluate the efficacy and safety of available options to optimize treatment selection and disease management.

Released: April 30, 2025

Share

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Evaluate therapeutic response and treatment advancement needs of patients with moderate to severe AD

  • Classify clinical characteristics of patients who would benefit from approved biologic therapies for moderate to severe AD